Integrating ADC Manufacturing for the Future - Abzena

Integrating ADC Manufacturing for the Future

Authors: Frigerio M and Cordova, J. C.

Publication: Pharma's Almanac

First published: 24 May 2019
Abstract

Antibody–drug conjugates (ADCs) in development target many indications beyond cancer and consist of a multitude of different types of components. Integrated development and manufacturing capabilities are essential to bringing these promising yet complex therapeutics to market.

Full paper available at: https://www.pharmasalmanac.com/articles/integrating-adc-manufacturing-for-the-future

Interested in our services? Get In Touch